MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20233082

January 19, 2023

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg,按C₂₁H₂₄FN₃O₄计)

化学药品

January 19, 2023

Company Information

Applicant Company

湖北省武汉市经济技术开发区高新技术工业园28号

Manufacturing Company

湖北省武汉市经济技术开发区高新技术工业园28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath